Related Experiment Video
Updated: Dec 8, 2025

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
Published on: September 13, 2024
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
Elizabeth A Thompson1,2, Katherine Cascino3, Alvaro A Ordonez4
1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Severe COVID-19 involves unique immune cell metabolic changes. Researchers identified specific T cells and myeloid-derived suppressor cells (MDSCs) linked to disease severity, offering potential therapeutic targets.
Area of Science:
- Immunology
- Metabolomics
- Cell Biology
Background:
- Understanding immune dysregulation in severe COVID-19 is crucial for patient outcomes.
- Distinct immune-metabolic programs differentiate severe disease from recovery or other viral infections.
Approach:
- A novel assay was used to analyze immune-metabolic programs in T cells and myeloid cells from severe and recovered COVID-19 patients.
- High-resolution microscopy and molecular techniques identified unique cell populations and their metabolic characteristics.
Key Points:
- Expanded T cells with high H3K27me3 and voltage-dependent anion channel (VDAC) expression were found in severe COVID-19, associated with mitochondrial dysfunction and apoptosis.
- Hexokinase II+ polymorphonuclear-myeloid derived suppressor cells (PMN-MDSCs) and carnitine palmitoyltransferase 1a (CPT1a)+ monocytic MDSCs (M-MDSCs) expressing VDAC were specific to severe COVID-19.
- These cellular phenotypes, particularly M-MDSCs, could distinguish severe from mild disease and were more prevalent in elderly patients, correlating with lymphopenia.
Conclusions:
- Novel immune-metabolic phenotypes in T cells and myeloid-derived suppressor cells are characteristic of severe COVID-19.
- These findings offer insights into immune dysfunction and provide potential biomarkers for disease severity prediction.
- Targeting these metabolic pathways presents opportunities for novel therapeutic interventions in severe COVID-19.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

